Dow Up0.11% Nasdaq Up0.50%

Cortex Pharmaceuticals, Inc. (CORX)

-Other OTC
0.04 0.00(0.00%) Aug 29, 9:30AM EDT
ProfileGet Profile for:
Cortex Pharmaceuticals, Inc.
126 Valley Road
Suite C
Glen Rock, NJ 07452
United States - Map
Phone: 201-906-2467

Index Membership:N/A
Industry:Drug Manufacturers - Other
Full Time Employees:6

Business Summary 

Cortex Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The company is involved in developing AMPAKINE compounds, which are novel small molecule compounds that modulate AMPA-type glutamate receptors, a complex of proteins involved in the communication between nerve cells in the mammalian brain. It focuses on the prevention of respiratory depression in post-surgical patients treated with anesthetics, analgesics, or sedatives; and respiratory depression risks related to chronic opioid therapy, without impacting the pain relief provided by the opioids. The company’s lead clinical compounds in Phase II clinical trial comprise CX717 for the treatment of adult patients with attention deficit hyperactivity disorder; and CX1739 for the treatment of sleep apnea. It is also developing AMPAKINE compounds for the treatment of Alzheimer’s disease, mild cognitive impairment, schizophrenia, and depression. The company was formerly known as X-Age, Inc. and changed its name to Cortex Pharmaceuticals, Inc. in August 1988. Cortex Pharmaceuticals, Inc. was founded in 1987 and is based in Glen Rock, New Jersey.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Cortex Pharmaceuticals, Inc.

Key Executives 
Dr. Arnold S. Lippa Ph.D., 67
Chairman, Chief Exec. Officer and Pres
Dr. Gary S. Lynch Ph.D., 71
Co-Founder, Scientific Director and Consultant
Mr. Robert Neal Weingarten , 62
Chief Financial Officer, VP and Director
Dr. Leslie J. Street Ph.D., 55
Sr. Director of Medicinal Chemistry
Mr. Jeff Eliot Margolis , 58
VP, Treasurer, Sec. and Director
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders